Celance and pulmonary hypertension Patient Reports February 11, 2012

Celance Side Effects Report #5273409-4
Celance side effect was reported by a Consumer or non-health professional from FRANCE on Mar 09, 2007. Male patient, 83 years of age, was diagnosed with parkinson's disease  and was treated with Celance. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, hyponatraemia, interstitial lung disease, pulmonary fibrosis , pulmonary hypertension , right ventricular failure, subileus. Celance dosage: 2 MG; QD; PO. During the same period patient was treated with CARBIDOPA, ENTACAPONE, LEVODOPA, PLAVIX, IKOREL. Patient was hospitalized. Patient died on 02/20/2007.

Celance Side Effects Report #4618387-3
Celance side effect was reported by a Physician from on Mar 07, 2005. Female patient, 72 years of age, was diagnosed with parkinson's disease  and was treated with Celance. After drug was administered, patient experienced the following side effects: aortic valve calcification, aortic valve incompetence, aortic valve stenosis, cardiac failure, cardiac murmur, hypotension, mitral valve disease, pulmonary hypertension . Celance dosage: 3 MG DAY. During the same period patient was treated with MODOPAR, STAVELO, COMTAN, CITALOPRAM HYDROBROMIDE, OXAZEPAM, AMITRIPTYLINE, FENOFIBRATE. Patient recovered.

Celance Side Effects Report #4686172-2
Celance side effect was reported by a Pharmacist from on May 23, 2005. Female patient, 65 years of age, was diagnosed with parkinson's disease  and was treated with Celance. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, aortic valve incompetence, asthenia, dyspnoea, left ventricular failure, mitral valve incompetence, oedema peripheral, pulmonary hypertension , tricuspid valve incompetence. Celance dosage: 3 MG DAY. During the same period patient was treated with TRIVASTAL. Patient was hospitalized. Patient recovered.